Tim Watkins

CTNM

Tim Watkins serves as officer: CMO & Head of Development at Contineum Therapeutics, Inc. (CTNM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$373.7K

Net Position

Net Seller

$373.7K

Companies Traded

CTNM

Active Period

Dec 2025 – Jul 2026

5 total trades

Most Recent

Sell CTNM

Jul 1, 2026 · $173.6K

Tim Watkins's Insider Trading at Contineum Therapeutics, Inc. (CTNM)

Buys

0 · $0.00

Sells

5 · $373.7K

Total Shares Bought

Total Shares Sold

25,277

CTNM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 1, 2026	Sell	10,833	$16.02	$173.6K	8,961
Mar 2, 2026	Sell	3,611	$15.02	$54.2K	0
Jan 30, 2026	Sell	3,611	$14.18	$51.2K	811
Jan 28, 2026	Sell	3,611	$14.18	$51.2K	0
Dec 29, 2025	Sell	3,611	$12.06	$43.6K	0

Related Insiders

Daniel S. Lorrain

officer: Chief Scientific Officer

CTNMSell · Jul 10, 2026

Carmine N. Stengone

director, officer: CEO and President

CTNMSell · Jul 8, 2026

Explore More Insider Trading Data

CTNM Insider Trading Activity

View all insider trades at Contineum Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity